Previous 10 | Next 10 |
home / stock / tbpmf / tbpmf news
OTTAWA, Nov. 11, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc., (TSX-V) (OTCQB: TBPMF), a leader in drug discovery and development for cannabinoid-based therapeutics, today confirmed its regulatory strategy of its CAUMZ TM (PPP011) inhalation drug product and provided additional updat...
Azevedos To Commercialize Awaye™ in Portugal, Tunisia and Mozambique in Q1 2020 Tetra to submit two non-prescription DIN applications in Canada Tetra to commercialize non-prescription drugs in USA OTTAWA, Oct. 30, 2019 (GLOBE NEWSWIRE) -- Tetra Natural Health (...
OTTAWA, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“ Tetra ” or “ TBP ”) today provides an update on its initiatives to bring its Caumz ® (PPP011) inhalation drug product to the market. The previous financing has allowed Tetra to ...
U.S. Food and Drug Administration (FDA) allows evaluation of CAUMZ Kit as a combination drug/device product, providing clarity on regulatory approval pathway This is a first step in the regulatory strategy to bring CAUMZ Kit to the market with additional FDA guidance anticipated by en...
OTTAWA, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc., (TSX-V: TBP) (OTCQB: TBPMF), a leader in drug discovery and development for cannabinoid-based therapeutics, today announced it has signed an agreement with Thorne Research Inc. and Onegevity Health LLC to form a joint venture,...
ORLEANS, Ontario, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc., a leader in drug discovery and development for cannabinoid-based therapeutics, announced today the company has engaged LifeSci Advisors LLC, a leading investor relations consultancy serving life science companies, an...
ORLEANS, Ontario, July 30, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“Tetra” or the “Corporation”) is pleased to announce that, after successfully completing a prospectus offering for aggregate gross proceeds of $8,050,000 on July 12, 2019 (the ...
The growth of the cannabis industry has made it possible for companies to offer investment opportunities through the major listing exchanges in Canada. Previously known as the Canadian Venture Exchange, the TSX Venture Exchange is the sibling listing to the larger Toronto Stock Exchange...
OTTAWA, ON, July 18, 2019 (GLOBE NEWSWIRE) -- Tetra Natural Heath, a subsidiary of Tetra Bio-Pharma (TSX VENTURE: TBP) (OTCQB: TBPMF), is pleased to announce that one of the largest food and convenience store chains in North America has committed to carry the Hemp Energy Drink in over 6...
Drug portfolio with U.S. granted patent protection for ophthalmic use, drug solubility and abuse deterrence; U.S. FDA provides positive response on painful dry eye development program; Panag completes a Phase 3 clinical trial for a topical pain reliever; Serenity© trial to launch i...
News, Short Squeeze, Breakout and More Instantly...
Tetra Bio-Pharma Inc Company Name:
TBPMF Stock Symbol:
OTCMKTS Market:
Tetra Bio-Pharma Inc Website:
(TheNewswire) Montreal – TheNewswire - August 1, 2023 – Tetra Bio-Pharma Inc. (“ Tetra ” or the “ Company ”) ( TSX:TBP ) ( OTC:TBPMF ) (FRA:JAM1) a leader in cannabinoid-derived drug discovery and development announced that...
(TheNewswire) MONTREAL, QUEBEC – TheNewswire – May 11, 2023 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP) (OTC:TBPMF) (FRA:JAM1), a leader in cannabinoid-derived drug discovery and development, today announced it has cancelled its New Drug Subm...
(TheNewswire) Montreal, QC - TheNewswire - March 10, 2023 - Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") (TSX:TBP) (OTC:TBPMF) (FRA:JAM1) , a leader in cannabinoid-derived drug discovery and development is pleased to announce Health Canada h...